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Significance of the Study
• Previous studies of cognitive impairment in patients with multiple sclerosis (MS) have not classified 
cognitively intact persons with poor visuospatial functions as a separate group. This study contributes 
to a better understanding of cognitive functioning of persons with MS and detection of different pat-
terns of cognitive decline in this population.
DOI: 10.1159/000499312
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Abstract
Objective: The purpose of this study was to ascertain wheth-
er the application of the Audio Recorded Cognitive Screen 
(ARCS) in cognitive functioning screening of persons with 
multiple sclerosis (MS) differentiates profiles of existing cog-
nitive deficits (CDs) and whether this instrument can dis-
criminate accurately between subjects who are cognitively 
intact (CI) and those with a cognitive disorder. Subjects and 
Methods: The research was conducted on a sample of 359 
subjects, with two subsets of participants: 108 persons with 
a relapsing-remitting form of MS and 251 persons from the 
general population. Results: We labeled the three profiles 
obtained by applying the ARCS questionnaire: the CI profile, 
the profile of CI with visuospatial difficulties, and the profile 
of persons with CD. Conclusion: ARCS has the ability to dif-
ferentiate persons with a CD from those without, both in a 
sample of persons suffering from MS and in a sample of per-
sons from the general population. This finding indicates that 
this instrument is well suited for profiling the cognitive sta-
tus into specific categories, which puts it among the instru-
ments with a wide range of implementation.
© 2019 The Author(s)
Published by S. Karger AG, Basel
Introduction
Cognitive dysfunction is a common outcome of mul-
tiple sclerosis (MS) that may affect quality of life, work 
outcomes, and social engagement throughout the course 
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of the disease [1, 2]. The prevalence of cognitive impair-
ment in MS is unclear, with estimates typically ranging 
from 20 to 70% [2, 3]. Cognitive dysfunction in MS most 
often manifests as decreased information processing 
speed, attention and memory deficits, impaired abstract 
thinking, or impaired executive function [4, 5]. Neverthe-
less, most research shows that although deficits can be de-
tected in multiple cognitive functions, most individuals 
with MS do not demonstrate impairments across all do-
mains of cognitive functioning [2–5]. Thus, in investigat-
ing disorders in which more than one cognitive deficit 
(CD) is expected, there is a need to apply assessment in-
struments that tap into a wide spectrum of cognitive func-
tions. This allows for the examination of varying cognitive 
profiles, which in turn may deferentially affect functional 
outcomes. The Audio Recorded Cognitive Screen (ARCS) 
[6] is an instrument intended to assess CDs across several 
functional domains. However, it is also possible that dif-
ferential cognitive profiles with varying patterns of CDs 
exist within the MS population, which in turn have differ-
ing functional outcomes or patterns of cognitive decline.
Compulsory screening for CDs has not been intro-
duced in the practice of health care systems by all coun-
tries. Most measuring instruments require a trained pro-
fessional and a considerable amount of time for admin-
istration and interpretation. ARCS does not require 
additional time since a trained nurse can administer it, 
and the interpretation takes 5 min. This is the main ratio-
nale behind the choice of the instrument used.
Therefore, the purpose of this study was to conduct an 
examination of the types of cognitive profiles that exist 
based on ARCS subtest performance, whether the derived 
cognitive profiles can discriminate between individuals 
with MS and healthy controls (HC), and differences be-
tween the profile groups on two commonly used tests of 
cognitive dysfunction in MS: the Symbol Digit Modalities 
Test (SDMT) and the Paced Auditory Serial Addition 
Test (PASAT).
The presence of CDs in persons with MS and the prob-
lems they cause is well established, but previous studies 
have not defined particular groups of problems. There-
fore, the specific goal of our study was to establish the 
profiles of CDs in individuals with MS.
Methods
Participants
This study was conducted in the Autonomous Province of Vo-
jvodina (Serbia) on a sample of 359 persons (age range: 18–55 
years) divided into two groups: a study group of patients with re-
lapsing-remitting MS (Expanded Disability Status Scale, EDSS, 
0–5.5) (n = 108), and a group of HC subjects recruited from the 
general population (n = 251). The inclusion criteria for the MS 
participants was a diagnosis of MS established according to Mc-
Donald criteria [7] and a EDSS score ranging from 0–5. The crite-
ria for excluding respondents from the study (MS and HC group) 
were diagnosed psychiatric disorders, history of the use of psycho-
active substances and alcohol, brain injuries, and the presence of 
other diseases that could influence the participation in the re-
search. The descriptive characteristics of both groups are shown in 
Table 1.
Instruments
The ARCS [8] is a screening instrument for the detection of 
cognitive impairment in patients with neurological conditions 
such as MS, schizophrenia, or traumatic brain injury. The ARCS 
allows the screening of multiple cognitive domains, and the test is 
minimally demanding with respect to time and equipment needed. 
The ARCS has eight subtests measuring six cognitive domains: de-
layed and immediate memory recall, verbal fluency, language 
(naming objects), visuospatial functions (clock-drawing), and at-
tention (The Hunter Attentional Task, HAT A and HAT B).
Table 1. Descriptive characteristics of the sample
MS
Gender Male: n = 38 (35.5%); female: n = 69 
(64.5%)
χ2 (1) = 0.07, p = 0.791
Education Primary school or less: n = 8 (7.47%)
Three years of high school: n = 20 
(18.69%)
Four years of high school: n = 52 
(48.59%)
BA, BSc, or equivalent: n = 25 (23.34%)
MA, MSC, or doctoral degree: n = 1 
(0.93)
χ2 (11) = 43.37, p < 0.001
Age Mean = 39.91, SD = 8.228, range: 20–53 
years 
(t(357) = 3.44, p <0.001)
First symptoms of MS Mean = 14.23, SD = 6.88, range: 4–34 
years
Duration of MS 
diagnosis
Mean = 10.74, SD = 5.19, range: 4–29 
years
HCs
Gender Male: n = 92 (36.7%); female: n = 159 
(63.3%)
Education Primary school or less: n = 8 (3.21%)
Three years of high school: n = 23 
(9.23%)
Four years of high school: n = 82 (32.9%)
BA, BSc, or equivalent: n = 96 (38.5%)
MA, MSc, or doctoral degree: n = 40 
(16.06%) 
Age Mean = 35.24, SD = 12.84, range: 18–65 
years
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The following instruments were also used in the assessment of 
cognitive profiles of MS subjects: (1) the SDMT [9], used for the 
assessment of visual scanning, tracking, and motor speed, i.e., in-
formation processing speed; and (2) the PASAT [10], used to eval-
uate working memory and information processing speed. These 
tests were selected because of their established efficacy in the 
screening of cognitive impairment in MS.
The EDSS [11] was used to evaluate the extent of neurological 
physical disability in the participants with MS.
Statistical Analysis
Latent profile analysis and multivariate analysis of variance 
(MANOVA) were performed to analyze the data using the statisti-
cal program package Mplus, version 7.32 [12]. The latent profile 
analysis is used to determine the number of homogenous or latent 
groups, and it is superior to cluster analysis [13]. For determining 
the number of latent groups, we used the Akaike Information Cri-
terion (AIC) [14], the Bayesian Information Criterion (BIC) [15], 
and the sample size-adjusted BIC (ssaBIC) [16], a lower value of 
which indicates a better model fit. Along with these indicators, we 
used the Lo-Mendell-Rubin adjusted likelihood ratio test (LRT) 
[17] to test whether the introduction of one more category (i.e., 
latent group) contributed to a significant change compared to the 
previously derived model. Among the indicators used for deter-
mining the number of latent profiles, we used entropy values [17], 
which indicate that the higher the values the better they fit the 
model, and theoretically a value of 1.00 represents a perfect clas-
sification.
Table 2. Descriptive statistics of ARCS subtests, SDMT, PASAT, and EDSS stratified by group
MS HC
range mean ± SD Sk SE Ku SE range mean ± SD Sk SE Ku SE tp
ARCS
Immediate recall 11–32 23.82±4.54 –0.25 0.23 –0.51 0.46 11–36 28.18±4.13 –0.66 0.15 0.91 0.31 –8.89**
Delayed recall 0–12 8.07±2.41 –0.53 0.23 0.22 0.46 0–12 10.10±1.81 –1.46 0.15 3.86 0.31 –8.90**
Visuospatial fun. 0–10 6.65±3.91 –0.63 0.23 –1.38 0.46 0–10 9.14±2.46 –3.06 0.15 8.06 0.31 –7.25**
Verbal fluency 12–51 31.01±8.02 0.08 0.23 0.031 0.46 9–69 38.64±8.60 –0.06 0.15 0.76 0.31 –7.86**
Language 3–10 8.48±1.55 –1.74 0.23 3.37 0.46 4–10 9.12±0.90 –1.59 0.15 44.80 0.31 –4.93**
Attention 0–40 17.21±8.81 0.14 0.23 –0.34 0.46 0–40 27.01±9.02 –0.25 0.15 –0.54 0.31 –9.46**
SDMT 3–68 39.99±13.31 –0.11 0.23 –0.46 0.46 na na na na na na /
PASAT 0–60 43.52±19.84 –1.44 0.23 0.72 0.46 na na na na na na /
EDSS 0–5 2.94±1.14 –0.12 0.23 –0.77 0.46 na na na na na na /** p < 0.01.
Table 3. Criteria for assessing fit for different number of classes
1 Class 2 Classes 3 Classes 4 Classes
AIC 12,000.032 11,295.927 10,982.348 10,920.927
BIC 12,046.598 12,369.657 11,083.242 11,048.984
ssaBIC 12,008.528 11,309.380 11,000.758 10,944.293
Entropy na 0.998 0.992 0.925
Lo-Mendell-Rubin test na 2 vs. 1
value 701.073
p = 0.000
3 vs. 2
value 319.810
p = 0.000
4 vs. 3
value 73.633
p = 0.361
N for each class C1 = 358 C1 = 57
C2 = 301
C1 = 66
C2 = 235
C3 = 57
C1 = 8
C2 = 65
C3 = 57
C4 = 228
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Results
The descriptive indicators of the ARCS subscales for 
subjects from the HC population and MS patients are 
shown in Table 2. In the MS group, all subtests had nor-
mal distributions. In the control group, the distribution 
of scores on the subscale of visuospatial function deviated 
slightly from the normal.
Latent Profile Analysis: Number and Content of 
Classes
The values of indicators used for the selection of the 
number of latent profiles (based on ARCS subtest scores) 
are shown in Table 3. The solution with one latent pro-
file did not show indicators of a good fit. When values 
of solutions with one and two latent profiles were com-
pared, AIC, BIC, and ssaBIC showed the solution with 
two latent profiles to be more parsimonious and to cor-
respond better with our data than the solution with one 
latent profile. The Lo-Mendell-Rubin test was signifi-
cant and indicated that the solution with two latent pro-
files was better than the one with only one latent profile. 
Testing the solution with three latent profiles yielded 
significantly lower AIC, BIC, and ssaBIC indicators 
compared to the previously tested solution. The values 
of the Lo-Mendell-Rubin test and entropy test indicated 
that the solution with three latent classes was better than 
the one with two latent classes. When the solution with 
four latent profiles was tested, the Lo-Mendell-Rubin 
test was not significant compared to the model with 
three latent profiles. Also, the value of entropy dropped 
significantly in the case of the four-profile solution. The 
results of the latent profile analysis, based on the AIC, 
BIC, ssaBIC, values of entropy, and the Lo-Mendell-Ru-
bin test, indicated that the best solution for this data was 
the one with three latent profiles. The first profile in-
cluded 66 subjects (CD = 19.8%), the second profile 235 
(cognitively intact [CI] = 64.3%), and the third profile 
57 subjects (CI but with visuospatial impairment 
[CIVSI] = 15.9%).
Table 4. Three-profile solution and comparison between scores
CD CI CIVSI FSig Post hoc test
Immediate recall 21.44±0.684 29.13±0.238 26.75±0.764 58.39** C2>C3>C1
Delayed recall 7.12±0.295 10.54±0.103 9.20±0.330 64.14** C2>C3>C1
Visuospatial fun. 9.64±0.132 9.86±0.046 1.10 ±0.148 1,606.78** C2>C1>C3
Verbal fluency 29.48±1.590 40.07±0.554 35.40±1.777 21.58** C2>C3>C1
Language 8.80±0.179 9.16±0.062 9.15±0.200 1.82 C1=C2=C3
Attention 15.96±1.608 28.86±0.560 21.65±1.797 33.55** C2>C3>C1
Values are presented as mean ± SD. CD, cognitive deficit; CI, cognitively intact; CIVSI, cognitively intact with visuospatial impairment ** p < 0.01; * p < 0.05.
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Fig. 1. Graphic presentation of the three-
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Table 4 and Figure 1 show means and standard devia-
tions of the ARCS subtest for the solution which included 
three latent profiles. The differences between profiles on 
the ARCS subtests were examined using MANOVA. The 
first latent profile consisted of 66 subjects who scored the 
lowest on four measures of cognitive function (immediate 
recall, delayed recall, verbal fluency, and attention), i.e., 
they had the lowest scores across all functional domains, 
except for language (which was equivalent across all pro-
files) and visuospatial functioning, where they achieved 
better results compared to the third profile, and poorer 
results compared to the second profile. This profile con-
sisted of subjects with a CD. The second profile consisted 
of 235 subjects who scored the highest on all measures, 
except on the language subtest. It can be said that this pro-
file included subjects who were CI. The third profile con-
sisted of 57 subjects who reached higher scores compared 
to subjects with CD, but lower than CI subjects on mea-
sures of delayed and immediate recall, verbal fluency, and 
attention. This profile was characterized by markedly 
poorer performance on measures of visuospatial func-
tioning, which was lower than that achieved by both CI 
and CD subjects. This included the CIVSI subjects.
When these latent profiles were applied to the initial 
classification of MS subjects, 26 subjects (24.1%) were 
classified as the CI profile, 43 subjects (40.2%) as the CD 
profile, while 38 subjects (35.2%) fitted the CIVSI profile. 
Among the HCs, 206 (82.1%) were classified as the CI 
profile, 25 (10%) as the CD profile, and 20 (8%) as the 
CIVSI profile.
Construct Validity of the ACRS Instrument
MANOVA showed that the group of MS participants 
classified on the basis of the latent profile analysis into CI, 
CD, and CIVSI differed in their performance on the PAS-
AT and SDMT tests, as well as EDSS scores (Table 5). By 
applying the Scheffé post hoc test, it was found that CD 
subjects had poorer EDSS scores (mean = 3.23, SD = 
0.177) than CI subjects (mean = 2.57, SD = 0.208). CIVSI 
subjects (mean = 2.95, SD = 0.184) did not have poorer 
EDSS scores than CI subjects.
CD subjects (mean = 38.28, SD = 3.028) had poorer 
working memory/processing speed scores (PASAT) than 
CI (mean = 49.45, SD = 3.556) and CIVSI (mean = 45.32, 
SD = 3.149) subjects. CIVSI subjects did not differ sig-
nificantly from CI subjects on the PASAT. CD subjects 
(mean = 34.57, SD = 1.908) performed more poorly 
on processing speed (SDMT) compared with CIVSI 
(mean = 38.43, SD = 1.984) and CI (mean = 49.07, SD = 
3.556) subjects. CIVSI subjects performed poorly on the 
SDMT compared to CI subjects.
Discussion
The purpose of this study was to conduct an examina-
tion of the types of cognitive profiles that exist based on 
the ARCS subtest performance, whether the derived cog-
nitive profiles can discriminate between individuals with 
MS and HC. The results of this study showed that latent 
profile analysis yielded three different profiles, based on 
the six cognitive functions assessed in the ARCS. The 
three profiles obtained were named “cognitively intact” 
(CI), “cognitively intact with visuospatial impairment” 
(CIVSI), and “cognitive deficit” (CD).
The results of this study indicated that there were no 
differences in scores on the language subtest across pro-
file classifications. This finding is consistent with previ-
ous studies, which also showed this domain of cognitive 
function to be the most preserved in MS patients [18]. 
With the exception of the language subtest, performance 
in all other cognitive ARCS subtest differed. Specifically, 
within the CD profile, the subjects performed worst on 
the subtests of immediate and delayed recall, attention, 
and verbal fluency. This finding is in accordance with re-
sults from a number of studies that have shown that pa-
Table 5. MANOVA showing the differences in the three profiles obtained on the standard neuropsychological 
battery
CD CI CIVSI FSig Post hoc test
EDSS 3.23±0.177 2.57±0.208 2.95±0.184 4.015* C1> (C2=C3)
PASAT 38.28±3.028 49.45±3.556 45.32±3.149 3.096* C1> (C2=C3)
SDMT 34.57±1.908 49.07±2.241 38.43±1.984 12.54** C1>C3>C2
Values are presented as mean ± SD. CD, cognitive deficit; CI, cognitively intact; CIVSI, cognitively intact with 
visuospatial impairment. ** p < 0.01; * p < 0.05.
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tients with clinically isolated symptoms and early-onset 
relapsing-remitting MS have dysfunctions in several cog-
nitive domains, which manifest as impaired information-
processing speed and memory [19]. This type of profile 
of cognitive functioning was found in 38.3% of our MS 
participants, which is very similar to the results of the 
study by López-Góngora et al. [20] who reported cogni-
tive impairment in 33.8% of MS patients during their 
1-year follow-up study using the PASAT and the SDMT 
instruments.
In our study, the group of subjects classified into the 
CD profile, in addition to showing poorer performance on 
the four cognitive functions (memory, attention, verbal 
fluency, and visuospatial functioning), also demonstrated 
poorer performance on other commonly used measures 
to assess cognitive dysfunction in MS, the PASAT, and 
SDMT, compared to the CI and CIVSI profile groups. MS 
participants classified as CD also had the most pronounced 
levels of disability, as indicated by higher EDSS scores, 
compared to the CI and CIVSI groups.
Interestingly, 10% of HC participants were character-
ized as CD. Palmer et al. [21] found a frequency of 1.8–
7.2% of CD in the general population, depending on the 
criteria used. On the other hand, a study by Ritchie et al. 
[22] showed that although the percentage of MCI in the 
general population was as low as 3.2%, when the process 
of ageing is taken into account, the percentage of cogni-
tive impairment in persons with “age-associated cogni-
tive decline” was as high as 19.3%.
The second latent profile of cognitive functioning 
(CIVSI) is characterized by a markedly low performance 
on the subtest of visuospatial functioning. Previous stud-
ies on cognitive impairment in MS patients have not clas-
sified cognitively intact persons with poor visuospatial 
functions as a separate group; however, they also found a 
relationship between visuospatial functions and global 
cognitive functioning in MS patients [23]. When this pro-
file was analyzed by comparing scores on other cognitive 
functions, these subjects were found to have better cogni-
tive functioning in the domains of recall (immediate and 
delayed), attention, and verbal fluency compared to sub-
jects classified as CD. Nevertheless, their functioning in 
these domains was not as good as that of the subjects from 
the CI profile. Their most important feature, apart from 
borderline functioning in all other domains, is a mark-
edly poor performance on the clock-drawing test. This is 
a complex task requiring engagement of cognitive func-
tions such as planning, visuospatial and visuoconstruc-
tive abilities, motor programming and performance, as 
well as abstract reasoning [24]. This test is recommended 
as a screening tool for early cognitive dysfunction [19, 
25], as it has shown high sensitivity and specificity for 
discriminating between MS patients with and without 
cognitive dysfunction [25]. Therefore, we can infer that 
this test can differentiate a group at risk for the develop-
ment of dysfunction where rehabilitation programs can 
be the most helpful. Within the MS group, 35.2% of all 
subjects were classified as CIVSI profile. Although visuo-
spatial functions have received less consideration in the 
literature [3], around 25% of MS patients have been re-
ported to have a deficit in visual perceptional functions 
[23]. Another important aspect of this latent profile is vi-
suomotor integration and planning. A study by Julian et 
al. [26] on a large sample of children with MS showed that 
pronounced deficits in visuomotor planning were pres-
ent even at a young age. Additionally, different aspects of 
visual perception can be affected in individuals with MS, 
such as the recognition of persons, perception of form, 
and visuospatial perception [23]. This calls for careful 
consideration when visuospatial functions in persons 
with MS are analyzed, as poorer functioning in this do-
main can be associated with the involvement of fine mo-
tor skills and executive functions. The CIVSI group of 
subjects had the same results on the measure of neuro-
logical deficits (EDSS) and equal scores on the assessment 
of attention and information processing speed (PASAT) 
as CI subjects. Based on the administration of these two 
tests within the standard test battery, CIVSI subjects 
would not be classified into a separate group. However, 
this profile scored lower than the CI profile on the SDMT. 
The SDMT showed a greater predictive value than the 
PASAT, which is in keeping with previous published 
findings [27].
The CI profile encompassed 82.1% of subjects from 
the HC group and 24.1% of subjects from the MS group. 
This profile is characterized by better performance in all 
five domains of the ARCS, compared to the CD and CIV-
SI profile groups. The percentage of subjects from the HC 
group classified into this profile is in line with previous 
research [21].
Subsequent studies should examine in more detail the 
characteristics of the CIVSI profile. Investigation of indi-
viduals from this profile could improve understanding of 
this profile. The present study did not evaluate factors af-
fecting cognitive functioning, such as depression, anxiety, 
and fatigue [28]. These additional data would be espe-
cially useful for the evaluation of CIVSI subjects.
Previous research has also shown that MS patients who 
have CDs participate less in social activities, have more 
problems in performing routine tasks, and are more sus-
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ceptible to psychiatric disorders compared to patients who 
have only motor impairment [29]. However, these factors 
may be differentially affected by differing cognitive profile 
types, and this needs to be examined in future research.
The major limitation of this study is a failure to use 
another standardized tool for assessment of cognitive 
function (traditional paper-and-pencil test) such as the 
BICAMS or RAO battery. Another major limitation of 
this study is that the evaluation of psychiatric symptoms 
such as apathy, depression, and anxiety was omitted.
Conclusion
ARCS shows the ability to differentiate persons with a 
CD from those without, both in a sample of persons suf-
fering from MS and in a sample of persons from the gen-
eral population. This finding points to this instrument 
being well suited for profiling the cognitive status into 
specific categories, which puts it among the instruments 
with a wide range of implementation.
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